Bile Duct

HERIZON-BTC-01 vs a Real-World Control Arm: Comparing Zanidatamab With Chemotherapy for Biliary Tract Cancer
Dr. Kim discusses survival outcomes of zanidatamab compared to chemotherapy in patients with previously treated HER2+ BTC.
Advertisement
Advertisement